+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effect of a herbal extract containing curcumin and piperine on midazolam, flurbiprofen and paracetamol (acetaminophen) pharmacokinetics in healthy volunteers



Effect of a herbal extract containing curcumin and piperine on midazolam, flurbiprofen and paracetamol (acetaminophen) pharmacokinetics in healthy volunteers



British Journal of Clinical Pharmacology 75(2): 450-462



Turmeric extract derived curcuminoids (curcumin, demethoxycurcumin and bisdemethoxycurcumin) are currently being evaluated for the treatment of cancer and Alzheimer's dementia. Previous in vitro studies indicate that curcuminoids and piperine (a black pepper derivative that enhances curcuminoid bioavailability) could inhibit human CYP3A, CYP2C9, UGT and SULT dependent drug metabolism. The aim of this study was to determine whether a commercially available curcuminoid/piperine extract alters the pharmacokinetic disposition of probe drugs for these enzymes in human volunteers. A randomized placebo-controlled six way crossover study was conducted in eight healthy volunteers. A standardized curcuminoid/piperine preparation (4 g curcuminoids plus 24 mg piperine) or matched placebo was given orally four times over 2 days before oral administration of midazolam (CYP3A probe), flurbiprofen (CYP2C9 probe) or paracetamol (acetaminophen) (dual UGT and SULT probe). Plasma and urine concentrations of drugs, metabolites and herbals were measured by HPLC. Subject sedation and electroencephalograph effects were also measured following midazolam dosing. Compared with placebo, the curcuminoid/piperine treatment produced no meaningful changes in plasma C(max), AUC, clearance, elimination half-life or metabolite levels of midazolam, flurbiprofen or paracetamol (α = 0.05, paired t-tests). There was also no effect of curcuminoid/piperine treatment on the pharmacodynamics of midazolam. Although curcuminoid and piperine concentrations were readily measured in plasma following glucuronidase/sulfatase treatment, unconjugated concentrations were consistently below the assay thresholds (0.05-0.08 μM and 0.6 μM, respectively). The results indicate that short term use of this piperine-enhanced curcuminoid preparation is unlikely to result in a clinically significant interaction involving CYP3A, CYP2C9 or the paracetamol conjugation enzymes.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052790824

Download citation: RISBibTeXText

PMID: 22725836

DOI: 10.1111/j.1365-2125.2012.04364.x


Related references

Effects of Schisandra sphenanthera extract on the pharmacokinetics of midazolam in healthy volunteers. British Journal of Clinical Pharmacology 67(5): 541-546, 2009

The effect of piperine on midazolam plasma concentration in healthy volunteers, a research on the CYP3A-involving metabolism. Daru 22(1): 8, 2014

The effect of piperine on pharmacokinetics of phenytoin in healthy volunteers. Planta Medica 53(6): 568-569, 1987

Effects of Ginkgo biloba extract on pharmacokinetics and pharmacodynamics of tolbutamide and midazolam in healthy volunteers. Journal of Clinical Pharmacology 46(11): 1290-1298, 2006

Effect of Piperine on the Metabolism and Pharmacokinetics of Carbamazepine in Healthy Volunteers. Drug Research 67(1): 46-51, 2017

Effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers. European Journal of Clinical Pharmacology 41(6): 615-617, 1991

Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Medica 64(4): 353-356, 1998

Effect of posaconazole on the pharmacokinetics of simvastatin and midazolam in healthy volunteers. Expert Opinion on Drug Metabolism and Toxicology 8(1): 1-10, 2012

Effect of itraconazole and terbinafine on the pharmacokinetics and pharmacodynamics of midazolam in healthy volunteers. British Journal of Clinical Pharmacology 40(3): 270-272, 1995

A phase I study of the effect of RP59500 on the pharmacokinetics of midazolam in healthy volunteers. Journal of Antimicrobial ChemoTherapy 44(Suppl. A): 56, 1999

Effect of erythromycin administration alone or coadministration with cimetidine on the pharmacokinetics of paracetamol in healthy volunteers. Asia Pacific Journal of Pharmacology 13(1): 19-23, 1998

Effect of zobo drink (Hibiscus sabdariffa water extract) on the pharmacokinetics of acetaminophen in human volunteers. European Journal of Drug Metabolism and Pharmacokinetics 29(1): 25-29, 2004

Effect of antiorthostatic hypokinesia on acetaminophen pharmacokinetics and its distribution in saliva of healthy volunteers. Pharmaceutical Chemistry Journal 43(5): 235-238, 2009

Effect of Schisandra chinensis extract and Ginkgo biloba extract on the pharmacokinetics of talinolol in healthy volunteers. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 39(3): 249-254, 2009

Effect of maraviroc on the pharmacokinetics of midazolam, lamivudine/zidovudine, and ethinyloestradiol/levonorgestrel in healthy volunteers. British Journal of Clinical Pharmacology 65(Suppl. 1): 19-26, 2008